» Articles » PMID: 12873585

Minimal Hepatic Encephalopathy and Extrapyramidal Signs in Patients with Cirrhosis

Overview
Specialty Gastroenterology
Date 2003 Jul 23
PMID 12873585
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Two types of neurological dysfunction can occur in compensated cirrhosis: 1) extrapyramidal signs related to the accumulation of manganese in the basal ganglia and 2) milder degrees of cognitive impairment known as minimal hepatic encephalopathy (mHE). We assessed whether there was any relationship between both disorders in 42 patients with compensated cirrhosis.

Methods: Minimal hepatic encephalopathy was diagnosed using a battery of manual neuropsychological tests. Cognitive functioning was assessed by the Mini-Mental State Examination. Extrapyramidal signs were evaluated by the Columbia scale.

Results: Minimal hepatic encephalopathy was diagnosed in 15 (35.7%) patients. A total of 52.4% of patients showed significant extrapyramidal signs. Scores for the Columbia scale were higher in the presence of mHE (mean +/- SD, 16.0 +/- 10.9 vs 5.3 +/- 7.1, p = 0.0004). In the bivariate analysis, mHE, Child-Pugh score, and Mini-Mental State Examination score were significantly associated with extrapyramidal signs, whereas in the multivariate analysis, mHE was the only independent variable related to extrapyramidal signs.

Conclusions: There was a link between extrapyramidal signs and diagnosis of mHE based on manual neuropsychological testing. This finding may be explained by the influence of extrapyramidal manifestations on test performance or by a real pathophysiological relationship between both disorders. Further studies are necessary to resolve this question.

Citing Articles

The Misdiagnosis and Underdiagnosis of Hepatic Encephalopathy.

Bloom P Clin Transl Gastroenterol. 2024; 16(2):e00784.

PMID: 39635997 PMC: 11845192. DOI: 10.14309/ctg.0000000000000784.


Nomenclature and definition of hepatic encephalopathy - An update.

Allampati S, Mullen K Clin Liver Dis (Hoboken). 2019; 5(3):68-70.

PMID: 31040953 PMC: 6490462. DOI: 10.1002/cld.449.


Dopamine agents for hepatic encephalopathy.

Junker A, Als-Nielsen B, Gluud C, Gluud L Cochrane Database Syst Rev. 2014; (2):CD003047.

PMID: 24515383 PMC: 10657483. DOI: 10.1002/14651858.CD003047.pub3.


Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study.

Koziarska D, Wunsch E, Milkiewicz M, Wojcicki M, Nowacki P, Milkiewicz P BMC Gastroenterol. 2013; 13:107.

PMID: 23815160 PMC: 3716589. DOI: 10.1186/1471-230X-13-107.


PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis.

Bajaj J, Thacker L, Wade J, Sanyal A, Heuman D, Sterling R Aliment Pharmacol Ther. 2011; 34(9):1123-32.

PMID: 21929591 PMC: 3989141. DOI: 10.1111/j.1365-2036.2011.04842.x.